First titration | Second titration | Third titration | Fourth and beyond titration | Current titration | Overall status | |
---|---|---|---|---|---|---|
Was the ACEI tolerated during? | ||||||
Yesa, n (%) | 54 (88.5) | 55 (90.2) | 51 (83.6) | 54 (88.5) | 53 (86.9) | 49 (80.3) |
No, n (%) | 7 (11.5) | 6 (9.8) | 10 (16.4) | 7 (11.5) | 8 (13.1) | 12 (19.7) |
Was the ACEI timely titrated during? | ||||||
Yes, n (%) | 26 (42.6) | 26 (42.6) | 27 (44.3) | 24 (39.3) | 23 (37.7) | 7 (11.5) |
No, n (%) | 35 (57.4) | 35 (57.4) | 34 (55.7) | 34 (55.7) | 38 (62.3) | 54 (88.5) |
Was the dose of ACEI optimized during? | ||||||
Yes, n (%) | 31 (50.8) | 35 (57.4) | 27 (44.3) | 29 (49.2) | 30 (49.2) | 17 (27.9) |
No, n (%) | 30 (49.2) | 26 (42.6) | 34 (55.7) | 32 (52.5) | 31 (50.8) | 44 (72.1) |
Was the overall ACEI treatment optimized? | ||||||
Yes, n (%) | 12 (19.7) | 15 (24.6) | 10 (16.4) | 12 (19.7) | 12 (19.7) | 2 (3.3) |
No, n (%) | 49 (80.3) | 46 (75.4) | 51 (83.6) | 49 (80.3) | 49 (80.3) | 59 (96.7) |